Drug project high-priority medications: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 36: Line 36:
| 2019||8||Balversa||Erdafitinib||[[Erdafitinib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Balversa Balversa]||4/12/2019
| 2019||8||Balversa||Erdafitinib||[[Erdafitinib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Balversa Balversa]||4/12/2019
|-
|-
| 2019||7||Evenity||Romosozumab-aqqg||[[Romosozumab-aqqg]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Evenity Evenity]||4/9/2019
| 2019||7||Evenity||Romosozumab||[[Romosozumab]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Evenity Evenity]||4/9/2019
|-
|-
| 2019||6||Mayzent||Siponimod||[[Siponimod]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Mayzent Mayzent]||3/26/2019
| 2019||6||Mayzent||Siponimod||[[Siponimod]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Mayzent Mayzent]||3/26/2019

Revision as of 12:57, 25 June 2019

   Mission Statement   
   Tutorial   
   Editor's Checklist   

WikiDoc Drug Project — High-Priority Medications

List of high-priority medications

Year No. Brand Name Active Ingredient Page Link DailyMed Search Approval Date
2019 12 Polivy Polatuzumab vedotin-piiq Polatuzumab vedotin-piiq Polivy 6/10/2019
2019 11 Piqray Alpelisib Alpelisib Piqray 5/24/2019
2019 10 Vyndaqel Tafamidis meglumine Tafamidis meglumine Vyndaqel 5/3/2019
2019 9 Skyrizi Risankizumab-rzaa Risankizumab-rzaa Skyrizi 4/23/2019
2019 8 Balversa Erdafitinib Erdafitinib Balversa 4/12/2019
2019 7 Evenity Romosozumab Romosozumab Evenity 4/9/2019
2019 6 Mayzent Siponimod Siponimod Mayzent 3/26/2019
2019 5 Sunosi Solriamfetol Solriamfetol Sunosi 3/20/2019
2019 4 Zulresso Brexanolone Brexanolone Zulresso 3/19/2019
2019 3 Egaten Triclabendazole Triclabendazole Egaten 2/13/2019
2019 2 Cablivi Caplacizumab Caplacizumab Cablivi 2/6/2019
2019 1 Jeuveau prabotulinum toxin type a powder prabotulinum toxin type a powder Jeuveau 2/1/2019
2018 59 Ultomiris Ravulizumab Ravulizumab Ultomiris 12/21/2018
2018 58 Elzonris Tagraxofusp-erzs Tagraxofusp-erzs Elzonris 12/21/2018
2018 57 Asparlas Calaspargase pegol-mknl Calaspargase pegol-mknl Asparlas 12/20/2018
2018 56 Motegrity Prucalopride Prucalopride Motegrity 12/14/2018
2018 55 Xospata Gilteritinib Gilteritinib Xospata 11/28/2018
2018 54 Firdapse Amifampridine Amifampridine Firdapse 11/28/2028
2018 53 Vitrakvi Larotrectinib Larotrectinib Vitrakvi 11/26/2018
2018 52 Daurismo Glasdegib Glasdegib Daurismo 11/21/2018
2018 51 Gamifant Emapalumab-lzsgemapalumab-lzsg Emapalumab-lzsgemapalumab-lzsg Gamifant 11/20/2018
2018 50 Aemcolo Rifamycin Rifamycin Aemcolo 11/16/2018
2018 49 Yupelri Revefenacin Revefenacin Yupelri 11/9/2018
2018 48 Lorbrena Lorlatinib Lorlatinib Lorbrena 11/2/2018
2018 47 Xofluza Baloxavir marboxil Baloxavir marboxil Xofluza 10/24/2018
2018 46 Talzenna Talazoparib Talazoparib Talzenna 10/16/2018
2018 45 Tegsedi Inotersen Inotersen Tegsedi 10/5/2018
2018 44 Revcovi Elapegademase-lvlr Elapegademase-lvlr Revcovi 10/5/2018
2018 43 Nuzyra Omadacycline Omadacycline Nuzyra 10/2/2018
2018 42 Seysara Sarecycline Sarecycline Seysara 10/1/2018
2018 41 Libtayo Cemiplimab-rwlc Cemiplimab-rwlc Libtayo 9/28/2018
2018 40 Vizimpro Dacomitinib Dacomitinib Vizimpro 9/27/2018
2018 39 Emgality Galcanezumab-gnlm Galcanezumab-gnlm Emgality 9/27/2018
2018 38 Copiktra Duvelisib Duvelisib Copiktra 9/24/2018
2018 37 Ajovy Fremanezumab-vfrm Fremanezumab-vfrm Ajovy 9/14/2018
2018 36 Lumoxiti Moxetumomab pasudotox-tdfk Moxetumomab pasudotox-tdfk Lumoxiti 9/13/2018
2018 35 Pifeltro Doravirine Doravirine Pifeltro 8/30/2018
2018 34 Xerava Eravacycline Eravacycline Xerava 8/27/2018
2018 33 Takhzyro Lanadelumab Lanadelumab Takhzyro 8/23/2018
2018 32 Oxervate Cenegermin-bkbj Cenegermin-bkbj Oxervate 8/22/2018
2018 31 Diacomit Stiripentol Stiripentol Diacomit 8/20/2018
2018 30 Galafold Migalastat Migalastat Galafold 8/10/2018
2018 29 Annovera Segesterone acetate and ethinyl estradiol vaginal system Segesterone acetate and ethinyl estradiol vaginal system Annovera 8/10/2018
2018 28 Onpattro Patisiran Patisiran Onpattro 8/10/2018
2018 27 Poteligeo Mogamulizumab-kpkc Mogamulizumab-kpkc Poteligeo 8/8/2018
2018 26 Mulpleta Lusutrombopag Lusutrombopag Mulpleta 7/31/2018
2018 25 Omegaven Fish oil triglycerides Fish oil triglycerides Omegaven 7/27/2018
2018 24 Orilissa Elagolix sodium Elagolix sodium Orilissa 7/23/2018
2018 23 Krintafel Tafenoquine Tafenoquine Krintafel 7/20/2018
2018 22 Tibsovo Ivosidenib Ivosidenib Tibsovo 7/20/2018
2018 21 TPOXX Tecovirimat Tecovirimat TPOXX 7/13/2018
2018 20 Braftovi Encorafenib Encorafenib Braftovi 6/27/2018
2018 19 Mektovi Binimetinib Binimetinib Mektovi 6/27/2018
2018 18 Zemdri Plazomicin Plazomicin Zemdri 6/25/2018
2018 17 Epidioloex Cannabidiol Cannabidiol Epidioloex 6/25/2018
2018 16 Moxidectin Moxidectin Moxidectin Moxidectin 6/13/2018
2018 15 Olumiant Baricitinib Baricitinib Olumiant 5/31/2018
2018 14 Palynziq Pegvaliase-pqpz Pegvaliase-pqpz Palynziq 5/24/2018
2018 13 Doptelet Avatrombopag Avatrombopag Doptelet 5/21/2018
2018 12 Lokelma Sodium zirconium cyclosilicate Sodium zirconium cyclosilicate Lokelma 5/18/2018
2018 11 Aimovig Erenumab-aooe Erenumab-aooe Aimovig 5/17/2018
2018 10 Lucemyra Lofexidine hydrochloride Lofexidine hydrochloride Lucemyra 5/16/2018
2018 9 Akynzeo Fosnetupitant and palonosetron Fosnetupitant and palonosetron Akynzeo 4/19/2018
2018 8 Crysvita Burosumab-twza Burosumab-twza Crysvita 4/17/2018
2018 7 Tavalisse Fostamatinib Fostamatinib Tavalisse 4/17/2018
2018 6 Ilumya Tildrakizumab Tildrakizumab Ilumya 3/20/2018
2018 5 Trogarzo Ibalizumab-uiyk Ibalizumab-uiyk Trogarzo 3/6/2018
2018 4 Erleada Apalutamide Apalutamide Erleada 2/14/2018
2018 3 Symdeko Tezacaftor; ivacaftor Tezacaftor; ivacaftor Symdeko 2/12/2018
2018 2 Biktarvy Bictegravir, embitcitabine, tenofovir alafenamide Bictegravir, embitcitabine, tenofovir alafenamide Biktarvy 2/7/2018
2018 1 Lutathera Lutetium lu 177 dotatate Lutetium lu 177 dotatate Lutathera 1/26/2018
Retrieved from "https://www.wikidoc.org/index.php?title=Drug_project_high-priority_medications&oldid=1573302"